Breaking News - The Fly

Open Search

ARQT

Arcutis Biotherapeutics

$

()

Arcutis Biotherapeutics appoints David Topper as CFO

ARQT

4/10/2024 - 08:04am

Sol-Gel Technologies collaboration partner first-to-file ANDA generic to Zoryve

SLGL , ARQT

4/1/2024 - 07:18am

Arcutis Biotherapeutics appoints Todd Tucker as CHRO

ARQT

3/11/2024 - 08:11am

Arcutis presents late-breaking data from INTEGUMENT-PED Phase 3 trial

ARQT

3/10/2024 - 16:09pm

Arcutis Biotherapeutics 15.79M share Spot Secondary priced at $9.50

ARQT

2/29/2024 - 06:43am

Arcutis Biotherapeutics announces $150M common stock offering

ARQT

2/28/2024 - 16:10pm

Arcutis gets $25M upfront in partnership deal with Japan's Sato for roflumilast

ARQT

2/28/2024 - 16:05pm

Arcutis Biotherapeutics price target raised by $8 at Needham, here's why

ARQT

2/28/2024 - 08:49am

Arcutis Biotherapeutics price target raised by $1 at Mizuho, here's why

ARQT

2/28/2024 - 07:22am

Arcutis Biotherapeutics reports Q4 EPS (72c), consensus (77c)

ARQT

2/27/2024 - 05:59am

Arcutis Biotherapeutics price target raised by $8 at Mizuho, here's why

ARQT

2/23/2024 - 06:55am

Short Report: Bears squeeze MicroStrategy as shares track bitcoin higher

BOWL , ARQT , SAVA

…

2/10/2024 - 11:26am

Arcutis Biotherapeutics files $300M mixed securities shelf

ARQT

1/31/2024 - 17:23pm

Arcutis announces JAAD published results from trial evaluating ZORYVE

ARQT

1/29/2024 - 08:12am

Arcutis Biotherapeutics announces launch of ZORYVE topical foam in U.S.

ARQT

1/22/2024 - 08:01am